242 related articles for article (PubMed ID: 18786339)
1. An overview of incretin clinical trials.
Garber AJ; Spann SJ
J Fam Pract; 2008 Sep; 57(9 Suppl):S10-8. PubMed ID: 18786339
[TBL] [Abstract][Full Text] [Related]
2. How to implement incretin therapy.
Cobble ME
J Fam Pract; 2008 Sep; 57(9 Suppl):S26-31. PubMed ID: 18786341
[TBL] [Abstract][Full Text] [Related]
3. GLP-1 agonists and dipeptidyl-peptidase IV inhibitors.
Gallwitz B
Handb Exp Pharmacol; 2011; (203):53-74. PubMed ID: 21484567
[TBL] [Abstract][Full Text] [Related]
4. DPP-4 inhibitors and GLP-1 analogues: for whom? Which place for incretins in the management of type 2 diabetic patients?
Halimi S
Diabetes Metab; 2008 Feb; 34 Suppl 2():S91-5. PubMed ID: 18640591
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of incretin-based therapies in patients with type 2 diabetes mellitus.
Gilbert MP; Pratley RE
Eur J Intern Med; 2009 Jul; 20 Suppl 2():S309-18. PubMed ID: 19580950
[TBL] [Abstract][Full Text] [Related]
6. Targeting the incretin system in type 2 diabetes mellitus.
Potenza M; Rayfield EJ
Mt Sinai J Med; 2009 Jun; 76(3):244-56. PubMed ID: 19421968
[TBL] [Abstract][Full Text] [Related]
7. Incretin-based therapies for type 2 diabetes mellitus: properties, functions, and clinical implications.
Nauck MA
Am J Med; 2011 Jan; 124(1 Suppl):S3-18. PubMed ID: 21194578
[TBL] [Abstract][Full Text] [Related]
8. Improving glucagon-like peptide-1 dynamics in patients with type 2 diabetes mellitus.
Freeman JS
J Am Osteopath Assoc; 2012 Jan; 112(1 Suppl 1):S2-6. PubMed ID: 22267300
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of incretin-based therapies in patients with type 2 diabetes mellitus.
Gilbert MP; Pratley RE
Am J Med; 2009 Jun; 122(6 Suppl):S11-24. PubMed ID: 19464424
[TBL] [Abstract][Full Text] [Related]
10. Incretin-based therapies in type 2 diabetes: a review of clinical results.
Bosi E; Lucotti P; Setola E; Monti L; Piatti PM
Diabetes Res Clin Pract; 2008 Dec; 82 Suppl 2():S102-7. PubMed ID: 19022515
[TBL] [Abstract][Full Text] [Related]
11. Dipeptidyl peptidase-IV inhibitors: a major new class of oral antidiabetic drug.
Idris I; Donnelly R
Diabetes Obes Metab; 2007 Mar; 9(2):153-65. PubMed ID: 17300591
[TBL] [Abstract][Full Text] [Related]
12. When oral agents fail: optimizing insulin therapy in the older adult.
Meece J
Consult Pharm; 2009 Jun; 24 Suppl B():11-7. PubMed ID: 19555131
[TBL] [Abstract][Full Text] [Related]
13. From the bench to the bedside: dipeptidyl peptidase IV inhibitors, a new class of oral antihyperglycemic agents.
Pei Z
Curr Opin Drug Discov Devel; 2008 Jul; 11(4):512-32. PubMed ID: 18600568
[TBL] [Abstract][Full Text] [Related]
14. Beyond glycemic control: the effects of incretin hormones in type 2 diabetes.
Martin CL
Diabetes Educ; 2008; 34 Suppl 3():66S-72S. PubMed ID: 18525067
[TBL] [Abstract][Full Text] [Related]
15. Incretins: the novel therapy of type 2 diabetes.
Thongtang N; Sriwijitkamol A
J Med Assoc Thai; 2008 Jun; 91(6):943-54. PubMed ID: 18697398
[TBL] [Abstract][Full Text] [Related]
16. Incorporating glucagon-like peptide-1 receptor agonists into clinical practice.
Spellman CW
J Am Osteopath Assoc; 2012 Jan; 112(1 Suppl 1):S7-15. PubMed ID: 22267302
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic approach of type 2 diabetes mellitus with GLP-1 based therapies.
Penfornis A; Borot S; Raccah D
Diabetes Metab; 2008 Feb; 34 Suppl 2():S78-90. PubMed ID: 18640590
[TBL] [Abstract][Full Text] [Related]
18. Incretin-based therapy in type 2 diabetes: An evidence based systematic review and meta-analysis.
Waldrop G; Zhong J; Peters M; Goud A; Chen YH; Davis SN; Mukherjee B; Rajagopalan S
J Diabetes Complications; 2018 Jan; 32(1):113-122. PubMed ID: 29074120
[TBL] [Abstract][Full Text] [Related]
19. Dipeptidylpeptidase-4 (DPP-4) inhibitors are favourable to glucagon-like peptide-1 (GLP-1) receptor agonists: yes.
Scheen AJ
Eur J Intern Med; 2012 Mar; 23(2):126-31. PubMed ID: 22284241
[TBL] [Abstract][Full Text] [Related]
20. Incretin based therapies for type 2 diabetes mellitus.
Ghosh S; Collier A; Elhadd T; Malik I
J Indian Med Assoc; 2008 Jun; 106(6):373-4, 383, 388. PubMed ID: 18839649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
